← Eichor
Study identifier: NCT06745557 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

Condition: Burns  ·  Sponsor: CUTISS AG

PhasePhase 3
Planned participants70
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

This multicentre phase III clinical trial will target adults and adolescents of 12 years and older with severe burns to confirm the efficacy and functionality of denovoSkin™ in achieving wound closure and reducing scarring in patients with deep partial and full-thickness burns as compared to split-thickness skin.

This description comes directly from the study's public registry record.

Talk to the study team

Daniela Marino  ·  +41 44 244 36 60  ·  clinicaltrials@cutiss.swiss

Always discuss trial participation with your own doctor first.

Locations (1)

Rode Kruis ZiekenhuisBeverwijk, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06745557